Shaping the future of Regenerative Medicine – PHI’s vision for QPI in Cell Therapy Manufacturing
Phase Holographic Imaging (PHI) is pleased to present a comprehensive opinion piece detailing the versatility and potential the Company sees for Quantitative Phase Imaging (QPI) technology in Regenerative Medicine. PHI outlines how QPI will offer enhanced cell quality control in the cell manufacturing process, thereby addressing a central puzzle piece for making cell-based therapies safe, affordable, and accessible for all. This perspective piece aims to engage stakeholders and portray PHI's future in the rapidly evolving and dynamic field of regenerative medicine. By sharing the Company’s